Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Jong-Soon Park"'
Autor:
Kaliyan Barathikannan, Ramachandran Chelliah, Selvakumar Vijayalakshmi, Fred Kwame Ofosu, Su-Jung Yeon, Deuk-Sik Lee, Jong-Soon Park, Nam-Hyeon Kim, Deog-Hwan Oh
Publikováno v:
ACS Omega, Vol 9, Iss 36, Pp 37636-37649 (2024)
Externí odkaz:
https://doaj.org/article/adaac3ae25da48538053a488afc72f57
Autor:
Kaliyan Barathikannan, Akanksha Tyagi, Lingyue Shan, Nam-Hyeon Kim, Deuk-Sik Lee, Jong-Soon Park, Ramachandran Chelliah, Deog-Hwan Oh
Publikováno v:
Life, Vol 13, Iss 2, p 374 (2023)
Naturally occurring phytochemicals from plants or grains are crucial in reducing various metabolic disorders. Bioactive phytonutrients are abundant in the Asian dietary staple, brown rice. This research evaluated the impact of lactic acid bacteria (L
Externí odkaz:
https://doaj.org/article/f2002e47ffa347afba8a5c7dd41fb960
Autor:
Jong-soon Park
Publikováno v:
THE CHOSON DYNASTY HISTORY ASSOCIATION. 104:133-160
Publikováno v:
Journal of the Korea Academia-Industrial cooperation Society. 24:21-31
Autor:
Amit Roy, Jong-Soon Park, Friedrich Graf Finckenstein, Brian Lestini, Akintunde Bello, Shruti Agrawal, Gaurav Bajaj, Xiaoning Wang, Yan Feng
Supplementary Table S1. Summary of clinical studies included in the E-R analyses Supplementary Table S2. Model-estimated HR of death (relative to median Cavg1 at 3 mg/kg: 26.9 µg/mL) Supplementary Figure S1. Kaplan-Meier plot of OS in NSCLC by terti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04329242078707f8b9a696db5975e70e
https://doi.org/10.1158/1078-0432.22468856.v1
https://doi.org/10.1158/1078-0432.22468856.v1
Autor:
Amit Roy, Jong-Soon Park, Friedrich Graf Finckenstein, Brian Lestini, Akintunde Bello, Shruti Agrawal, Gaurav Bajaj, Xiaoning Wang, Yan Feng
Purpose: Nivolumab is a fully human IgG4 monoclonal antiprogrammed death-1 antibody with demonstrated efficacy, including durable responses and prolonged survival, in patients with previously treated, advanced non–small cell lung cancer (NSCLC). Ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ecc2446d1fba59eccbde68f7f2ddf2d
https://doi.org/10.1158/1078-0432.c.6527078.v1
https://doi.org/10.1158/1078-0432.c.6527078.v1
Publikováno v:
Journal of the Korea Academia-Industrial cooperation Society. 23:538-547
Autor:
JongMan Lee, Jong Soon Park
Publikováno v:
Journal of the Korea Society of Digital Industry and Information Management. 12:145-161
Autor:
Manish Gupta, Xiaoning Wang, Amit Roy, Gaurav Bajaj, Brian Lestini, Shruti Agrawal, Yang A, Jong-Soon Park, Yan Feng
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. 6:40-48
To inform the benefit-risk assessment of nivolumab in patients with advanced melanoma, analyses of efficacy and safety exposure-response (E-R) relationships were conducted with data from patients with advanced melanoma enrolled in two clinical studie
Publikováno v:
Journal of the Korea Academia-Industrial cooperation Society. 17:718-723